Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 11Observational 1

Sponsor

Cancer Type

Lymphoid 3Other hematologic neoplasm 2Plasma cell 1Myeloid 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Multiple Myeloma 463Neoplasms, Plasma Cell 81Lymphoma 75Leukemia 51Lymphoma, Non-Hodgkin 49Leukemia, Lymphocytic, Chronic, B-Cell 45Myelodysplastic Syndromes 43Immunoglobulin Light-chain Amyloidosis 42Leukemia, Myeloid, Acute 39Hodgkin Disease 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Neoplasms 32Hematologic Neoplasms 31Breast Neoplasms 31Myeloproliferative Disorders 29Lymphoma, Large B-Cell, Diffuse 29Lymphoma, Follicular 29Monoclonal Gammopathy of Undetermined Significance 28Smoldering Multiple Myeloma 25Lymphoma, Mantle-Cell 25Lymphoma, B-Cell, Marginal Zone 24Recurrence 23Burkitt Lymphoma 21Amyloidosis 21Prostatic Neoplasms 20Lymphoma, T-Cell, Cutaneous 20Lymphoma, Large-Cell, Immunoblastic 19Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 19Waldenstrom Macroglobulinemia 18Sezary Syndrome 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Immune System Diseases × Plasma cell × Clear all
NCT04830046 2025-11-26

Covid-19 Vaccine Responsiveness in MM and Waldenstrom

Massachusetts General Hospital

Completed
146 enrolled
LymphoidPlasma cell

COVID-19, Immune System Diseases, Waldenstrom Macroglobulinemia, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡